Investor Information

News

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

View News

Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors

View News

More Information

Share Price

NASDAQ: SMMT

9.47 USD

15-Jul-2024 16:00 UTC-4

More Information

SEC Filings

Current report filing

View News

Statement of changes in beneficial ownership of securities

View News

More Information

Email Alerts